Zobrazeno 1 - 10
of 23
pro vyhledávání: '"L. K. Everson"'
Human leukocyte interferon was injected into nine patients with cytomegalovirus infections; four of these patients were congenitally infected, and five had acquired infections. In three patients viruria was completely inhibited. In five patients vira
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebe82ea65ed7e9efd233c1070cec6dc5
http://doc.rero.ch/record/301047/files/133-Supplement_2-A199.pdf
http://doc.rero.ch/record/301047/files/133-Supplement_2-A199.pdf
Autor:
S F Brunk, Robert F. Marschke, Michael H. Veeder, James A. Mailliard, L K Everson, D I Twito, James R. Jett, Robert J. Dalton, James E. Krook, Terry M. Therneau
Publikováno v:
Journal of Clinical Oncology. 8:33-38
In this randomized study involving patients with limited-stage small-cell lung cancer (LD-SCC), we compared treatment with either cyclophosphamide; doxorubicin, and vincristine (CAV) or CAV plus etoposide (CAVE). All patients received identical thora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02596f3ae90cb761bde9c8de44261f52
https://doi.org/10.1200/jco.1990.8.1.33
https://doi.org/10.1200/jco.1990.8.1.33
Autor:
Harry J. Long, Daniel J. Schaid, James N. Ingle, L K Everson, Greg W. McCormack, James A. Mailliard, James E. Krook
Publikováno v:
American journal of clinical oncology. 13(2)
Trilostane, which causes a perturbation of adrenal steroidogenesis, was studied in combination with hydrocortisone in 32 women with progressive metastatic breast cancer. Trilostane was administered orally at a dosage level of 240 mg four times daily
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65ee6d33ca14d0d2cfe60fed214117f0
https://pubmed.ncbi.nlm.nih.gov/2316487
https://pubmed.ncbi.nlm.nih.gov/2316487
Autor:
David L. Ahmann, Stephen A. Cullinan, James E. Krook, James N. Ingle, Judith R. O'Fallon, Jan C. Buckner, Delano M. Pfeifle, L K Everson
Publikováno v:
Breast Cancer Research and Treatment. 13:135-142
We have evaluated the results of salvage systemic therapy in 257 patients with breast cancer recurrent after surgical adjuvant treatment with cyclophosphamide, fluorouracil, and prednisone (CFP) with or without tamoxifen. The overall objective respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3d9c8ac303a023d7f728167518bb98
https://doi.org/10.1007/bf01806525
https://doi.org/10.1007/bf01806525
Autor:
James E. Krook, S A Cullinan, Robert F. Marschke, L K Everson, John A. Laurie, D J Klaassen, Charles G. Moertel, T R Buroker, James A. Mailliard, Thomas R. Fleming
Publikováno v:
Journal of Clinical Oncology. 3:1624-1631
Three hundred thirty-five previously untreated patients with advanced colorectal carcinoma were randomly assigned to treatment with 5-fluorouracil (5-FU) alone, 5-FU plus N-(phosphonacetyl)-L-aspartic acid (PALA), 5-FU plus high-dose thymidine, 5-FU
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82bd6bad4651e936098b0e54bc95c08
https://doi.org/10.1200/jco.1985.3.12.1624
https://doi.org/10.1200/jco.1985.3.12.1624
Publikováno v:
JNCI: Journal of the National Cancer Institute. 53:913-920
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6730ecae65c293881a0d29728582730a
https://doi.org/10.1093/jnci/53.4.913
https://doi.org/10.1093/jnci/53.4.913
Autor:
JN Ingle, H E Windschitl, D I Twito, David L. Ahmann, James E. Krook, M N Chang, Harry F. Bisel, T P Kubista, L K Everson, Green Sj
Publikováno v:
Journal of Clinical Oncology. 4:178-185
A randomized clinical trial was performed to compare the efficacy of bilateral oophorectomy with that of tamoxifen at a dose of 10 mg twice daily in premenopausal women with metastatic breast cancer, and to examine the efficacy of each as a crossover
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::186cb97786fdf304aacc8122698a64b3
https://doi.org/10.1200/jco.1986.4.2.178
https://doi.org/10.1200/jco.1986.4.2.178
Autor:
James N. Ingle, James E. Krook, L K Everson, Robert G. Fitzgibbons, David L. Ahmann, Delano M. Pfeifle, J. Kirk Martin, Stephanie Green, John F. Foley, Jeffrey B. Hagen, Stephen A. Cullinan, Lester E. Wold, H. Sam Wieand
Publikováno v:
Cancer. 63:1257-1264
A randomized clinical trial was performed to determine if the addition of hormonal therapy with tamoxifen to a combination chemotherapy regimen was superior to the chemotherapy alone for adjuvant treatment of premenopausal women after mastectomy for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::683f9e947f788d823ebd7c908a72961b
https://doi.org/10.1002/1097-0142(19890401)63:7<1257::aid-cncr2820630705>3.0.co
https://doi.org/10.1002/1097-0142(19890401)63:7<1257::aid-cncr2820630705>3.0.co
Autor:
Robert P. Dinapoli, Terrence L. Cascino, Judith R. O'Fallon, Robert F. Marschke, Roscoe F. Morton, L. D. Brown, L K Everson
Publikováno v:
American Journal of Clinical Oncology. 11:586-588
Fifteen patients with recurrent primary brain tumors were treated with fludarabine phosphate. There were no responses seen. Toxicity was mild and primarily hematological. Fludarabine phosphate would appear to be ineffective in recurrent gliomas.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37de46dce9138121fbdecd8b45462830
https://doi.org/10.1097/00000421-198810000-00015
https://doi.org/10.1097/00000421-198810000-00015
Autor:
J N, Ingle, L K, Everson, H S, Wieand, S A, Cullinan, L E, Wold, J B, Hagen, J K, Martin, J E, Krook, R G, Fitzgibbons, J F, Foley
Publikováno v:
Cancer. 63(7)
A randomized clinical trial was performed to determine if the addition of hormonal therapy with tamoxifen to a combination chemotherapy regimen was superior to the chemotherapy alone for adjuvant treatment of premenopausal women after mastectomy for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dcacf33e7e3a9d8ae4377dce3b4a818d
https://pubmed.ncbi.nlm.nih.gov/2646004
https://pubmed.ncbi.nlm.nih.gov/2646004